Invictus RG (Singapore)’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Invictus RG (Singapore)’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,300	Closed	-$283K	–	775
2015 Q1	$283K	Buy	7,300 +4,800	+192%	+$185K	0.27%	131
2014 Q4	$84K	Buy	2,500 +2,000	+400%	+$70.6K	0.09%	316
2014 Q3	$18K	Buy	+500	New	+$17.1K	0.02%	472
2014 Q2	–	Sell	-4,100	Closed	-$151K	–	784
2014 Q1	$151K	Sell	4,100 -12,000	-75%	-$440K	0.18%	212
2013 Q4	$618K	Buy	+16,100	New	+$508K	0.42%	45

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Invictus RG (Singapore)'s WX Position: Q2 2015 in Review

Invictus RG (Singapore) sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 7,300 shares — an estimated $283K sold.

Invictus RG (Singapore) first reported a position in WX in Q4 2013 and held it in 5 quarters. The position peaked at $618K in Q4 2013. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

Invictus RG (Singapore) reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
Invictus RG (Singapore) sold 7,300 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $283K.
Invictus RG (Singapore) first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 5 quarters.
Invictus RG (Singapore)'s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $618K in Q4 2013.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q2 2015, filed 13 Aug 2015.